Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnox M Plus 1mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Noxin Biocare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glimnox M Plus 1mg/1000mg Tablet SR

Diabexe Duo 1mg/1000mg Extended-Release Tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. This formulation aids in regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Glimnox M Plus 1mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimnox M Plus 1mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimnox M Plus 1mg/1000mg Tablet SR. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with a meal.

Common Side effects of Glimnox M Plus 1mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnox M Plus 1mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimnox M Plus 1mg/1000mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.

How Glimnox M Plus 1mg/1000mg Tablet SR works:

Glimnox M Plus 1mg/1000mg Extended-Release tablets combine glimepiride and metformin, two agents effective in diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimnox M Plus 1mg/1000mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimnox M Plus 1mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Glimnox M Plus 1mg/1000mg SR tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimnox M Plus 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimnox M Plus 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with severe liver disease should avoid this medication. A lower starting dose is typically advised for those with mild to moderate liver dysfunction. Physician consultation is essential.

What if you forget to take Glimnox M Plus 1mg/1000mg Tablet SR :

Should you forget a Glimnox M Plus 1mg/1000mg SR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimnox M Plus 1mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimnox M Plus 1mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimnox M Plus 1mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimnox M Plus and seek immediate medical attention.
Glimnox M Plus 1mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimnox M Plus 1mg/1000mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Glimnox M Plus 1mg/1000mg Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glimnox M Plus 1mg/1000mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimnox M Plus 1mg/1000mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, increasing the risk of hypoglycemia and lactic acidosis.
Glimnox M Plus 1mg/1000mg...
103
MRP 126
18% off